​

Vivos Therapeutics (VVOS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

VVOS Stock Forecast

Vivos Therapeutics (VVOS) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $2.25, with a high of $2.25 and a low of $2.25. This represents a -17.28% decline from the last price of $2.72.

- $3 $6 $9 $12 $15 High: $2.25 Avg: $2.25 Low: $2.25 Last Closed Price: $2.72

VVOS Stock Rating

Vivos Therapeutics stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

VVOS Price Target Upside V Benchmarks

TypeNameUpside
StockVivos Therapeutics-17.28%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks18.84%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$2.25
Last Closing Price$2.72$2.72$2.72
Upside/Downside---17.28%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25-11--2
Sep, 25-11--2
Aug, 25-11--2
Jul, 25-11--2
Jun, 25-11--2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 20, 2025Scott HenryIndustrial Alliance Securities$2.25$2.154.65%-17.28%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 20, 2025Alliance Global PartnersBuyNeutraldowngrade
Apr 01, 2025Alliance Global PartnersBuyBuyhold

Financial Forecast

EPS Forecast

$-30 $-24 $-18 $-12 $-6 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25
Reported$-12.11$-23.89$-24.62$-11.14--
Avg Forecast$-15.00$-22.50$-26.50$-10.52$-2.02$-1.07
High Forecast$-15.00$-22.50$-25.94$-10.20$-1.96$-1.03
Low Forecast$-15.00$-22.50$-27.06$-10.83$-2.08$-1.10
Surprise %-19.27%6.18%-7.09%5.89%--

Revenue Forecast

$13M $14M $16M $17M $19M $20M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25
Reported$13.07M$16.89M$16.02M$13.80M$15.03M-
Avg Forecast$12.94M$17.30M$16.55M$13.98M$15.20M$19.16M
High Forecast$12.94M$17.30M$16.82M$14.30M$15.55M$19.60M
Low Forecast$12.94M$17.30M$16.28M$13.66M$14.85M$18.72M
Surprise %0.99%-2.40%-3.17%-1.30%-1.12%-

Net Income Forecast

$-35M $-28M $-21M $-14M $-7M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25
Reported$-8.82M$-20.29M$-22.66M$-13.58M--
Avg Forecast$-18.29M$-27.44M$-32.31M$-12.82M$-2.46M$-1.30M
High Forecast$-18.29M$-27.44M$-31.63M$-12.44M$-2.39M$-1.26M
Low Forecast$-18.29M$-27.44M$-33.00M$-13.20M$-2.54M$-1.34M
Surprise %-51.76%-26.04%-29.88%5.94%--

VVOS Forecast FAQ

Is Vivos Therapeutics stock a buy?

Vivos Therapeutics stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Vivos Therapeutics is a favorable investment for most analysts.

What is Vivos Therapeutics's price target?

Vivos Therapeutics's price target, set by 4 Wall Street analysts, averages $2.25 over the next 12 months. The price target range spans from $2.25 at the low end to $2.25 at the high end, suggesting a potential -17.28% change from the previous closing price of $2.72.

How does Vivos Therapeutics stock forecast compare to its benchmarks?

Vivos Therapeutics's stock forecast shows a -17.28% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (18.84%).

What is the breakdown of analyst ratings for Vivos Therapeutics over the past three months?

  • October 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Vivos Therapeutics’s EPS forecast?

Vivos Therapeutics's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.07, marking a 0% decrease from the reported $0 in 2024..

What is Vivos Therapeutics’s revenue forecast?

Vivos Therapeutics's average annual revenue forecast for its fiscal year ending in December 2025 is $19.16M, reflecting a 27.45% increase from the reported $15.03M in 2024.

What is Vivos Therapeutics’s net income forecast?

Vivos Therapeutics's net income forecast for the fiscal year ending in December 2025 stands at $-1.299M, representing a 0% decrease from the reported $0 in 2024.